This information was published on 2025-02-10T11:25:55 for IP Right Registration Published.
| Field | Value |
| (210) | 2502654 (IR 1825077) |
| (220) |
24 Oct 2024
|
| (300) |
US, 28 Jun 2024, 98625107
|
| (511) (510) |
Class 5
Pharmaceutical preparations and substances for the treatment of neurological, neuropsychiatric, neurodegenerative, viral, metabolic, obesity, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, osteogenesis, immune system, central nervous system, peripheral nervous system, and voluntary muscle movement related diseases and disorders. |
| (540) | LOVMYEN |
| (550) | Word |
| (730) |
Biohaven Therapeutics Ltd.
|
Find out more about publications on the About page.